Shionogi’s Disclosure Policy states that as a company trusted widely by society, the Company recognizes that management transparency is one of its most important responsibilities. Based on this recognition, the Company discloses information to all stakeholders in a fair, timely, appropriate and continuous manner.

In our communication with shareholders and investors, the Company subscribes to a spirit of fair disclosure. In addition to disclosing information fairly and at the appropriate time, management and the department in charge of investor relations cooperate in proactive initiatives to promote sustained growth and increase corporate value over the medium and long term.

In addition, we have created a system to encourage closer cooperation among departments, facilitating dialog regarding issues including management strategy, shares, investor relations, finance, and ESG. We also have appointed an officer to oversee this system.

[Key IR activities in fiscal 2018] Results briefings for analysts and institutional investors: Four in total / Briefings for analysts and institutional investors: 13 in total (R&D briefing, briefing concerning Sage Therapeutics, and 11 small meetings with analysts and institutional investors) / Communication with domestic investors: Total of 326 companies / Communication with overseas investors: Total of 168 companies / Participation in conferences hosted by securities companies: Five times in total [Key instances of IR recognition in fiscal 2018] All-Japan Executive Team {Pharmaceuticals} Most Honored Companies: First, Best CEOs: First, Best IR Professionals: Second, Best IR Programs: First, Best ESG/SRI Metrics: Second, Best Corporate Governance: First / Selected among “Companies with Greatest Improvement in IR” in Japan Investor Relations Association’s 25th Anniversary Commemorative Award / Received “Award for Excellence in Corporate Disclosure” from the Securities Analysts Association of Japan (ranked first in the pharmaceuticals sector) / Selected by Government Pension Investment Fund among companies with “Most-Improved Integrated Reports”
Numbers of communication with investors